Skip to main content
. 2017 Aug 17;8(44):77975–77989. doi: 10.18632/oncotarget.20316

Table 1. Summary of articles reviewed.

Modality No. of Articles (Whole gland/PZ/TZ) No. of individuals (Whole gland/PZ/TZ)
By biopsy DCE 12/6/2 8781 /3040/563
DWI 8/5/1 7242/2285/1117
DCE and DWI 2/1/0 2133/ 709/ND
MRS 2/1/0 854/31/ ND
T2 11/6/4 7187/3463/1558
DCE and T2 2/0/1 1088/ND/42
DWI and T2 1/0/2 424/ND/678
DCE, DWI, and T2 7/1/3 4900/1134/1246
DCE, DWI, MRS and T2 1 /0 /0 605/ND/ND
By patients DCE 2 122
DWI 2 120
T2 3 145
DCE and T2 2 598
DWI and T2 2 90
DCE, DWI, and T2 4 276
DCE, DWI, MRS and T2 2 142
T2 and MRS 1 70

Abbreviations: DCE: dynamic contrast-enhanced magnetic resonance; DWI: diffusion weighted imaging; T2: T2 weighted imaging; MRS: magnetic resonance spectroscopy; WR: whole region; PZ: peripheral zone; TZ: transition zone; ND: no data.